My Account
79996.60 -0.07%
73038.00 0.93%
993.65 -0.46%
3177.25 2.23%
the jm financial report with target came out to general public on 5 sept it seems , i checked it today only , that explains initial spike and subsequent volumes spurt , crucially the report says jm financial fairly confident that krsnaa will deliver 40% or more revenue growth and 1050 target is assuming 40% discount to other lzb shares like thyrocare etc , it seems jm financial comparing price of per lab test compared to metropolis and dr.lal etc , though krsnaa charges less its cost is comparatively even less as it doesnt pay for real estate , doctors commission etc , so as more centres operationalized its margin going to explode ,and once operations stabilised volumes boost both government patients and private walk ins will amplify boosting profit margins even higher , actually the MOAT krsnaa built in government hospital business became a MONOPOLY in government hospital business , this not even one brokerages realized , discerning investors accumulating daily close to 45% about 1lakh shares in delivery based buying past few months , and reflected in both foreigners and mutual funds holding increasing every quarter
Your permanent Nickname can be distinct from your username and no one need know the link between the two.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
You are already a Moneycontrol Pro user.